SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-094925
Filing Date
2021-07-22
Accepted
2021-07-22 16:30:29
Documents
6
Period of Report
2021-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2116168d6_6k.htm 6-K 16564
2 EXHIBIT 5.1 tm2116168d6_ex5-1.htm EX-5.1 50021
3 EXHIBIT 10.1 tm2116168d6_ex10-1.htm EX-10.1 72308
4 EXHIBIT 10.2 tm2116168d6_ex10-2.htm EX-10.2 67313
5 GRAPHIC tm2116168d6_ex5-1img001.jpg GRAPHIC 5211
6 GRAPHIC tm2116168d6_ex5-1img002.jpg GRAPHIC 30685
  Complete submission text file 0001104659-21-094925.txt   257028
Mailing Address 801 BIXING STREET BIHU COUNTY LISHUI, ZHEJIANG PROVINCE F4 323006
Business Address 801 BIXING STREET BIHU COUNTY LISHUI, ZHEJIANG PROVINCE F4 323006 8657820516666
AnPac Bio-Medical Science Co., Ltd. (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 6-K | Act: 34 | File No.: 001-39137 | Film No.: 211107956
SIC: 8071 Services-Medical Laboratories